SFX by Ex Libris Inc.

Title:	Mechanism of activation of protein kinase JAK2 by the growth hormone receptor
Source:	Science [0036-8075] Brooks, A J yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wilkinson, Ian R R. "A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist." Nature medicine 13.9 (2007): 1108-1113.
description	2.	Chen, W. "Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes." Journal of biological chemistry 286.40 (2011): 34559-34566.
description	3.	Luisi, F. "Neuroendocrine aspects of placenta and pregnancy." Gynecological endocrinology 28.SUPPL.1 (2012): 22-26.
description	4.	Maciejewski, M. "Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2." Nature 468.7325 (2010): 839-843.
description	5.	Li, Al-Azzawi F. "Mechanism of androgen receptor action." Maturitas 63.2 (2009): 142-8.
description	6.	Burton, Graham J. "Regulation of vascular growth and function in human placenta." Reproduction 138.6 (2009): 895-902.
description	7.	Suh, Ji Ho H. "Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor-beta signaling by repressing SMAD3 transactivation." The Journal of biological chemistry 281.51 (2006): 39169-78.
description	8.	Kim, Su J. "Pharmacokinetics, Pharmacodynamics, and Efficacy of a Novel Long-Acting Human Growth Hormone: Fc Fusion Protein." Molecular pharmaceutics 12.10 (2015): 3759-3765.
description	9.	Xu, J. "Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models----Association with liver and adipose tissue effects." American journal of physiology: endocrinology and metabolism 297.5 (2009): 1105-14.
description	10.	Michels, G. "Rapid actions of androgens." Frontiers in neuroendocrinology 29.2 (2008): 182-198.
description	11.	Langemeijer, Saskia M C M. "Acquired mutations in TET2 are common in myelodysplastic syndromes." Nature Genetics 41.7 (2009): 838-42.
description	12.	Brunton, Paula J. "Allopregnanolone in the brain: protecting pregnancy and birth outcomes." Progress in Neurobiology 113 (2013): 106-136.
description	13.	Pradhananga, Eric L. "Immunogenicity, toxicology, pharmacokinetics and pharmacodynamics of growth hormone ligand-receptor fusions." Clinical science 119.11 (2010): 483-91.
description	14.	Leversen, Katrine T. "Prediction of outcome at 5 years from assessments at 2 years among extremely preterm children: A Norwegian national cohort study." Acta pædiatrica 101.3 (2011): 264-270.
description	15.	Valdés S, G. "[Human pregnancy, a biological paradigm of tolerance and adaptation]." Revista médica de Chile 139.3 (2011): 400-405.
description	16.	Bacurau, R F. "Hormonal, metabolic and perceptual responses to different resistance training systems." Journal of Sports Medicine and Physical Fitness 50.2 (2010): 229-234.
description	17.	Brooks, Andrew J. "The growth hormone receptor: mechanism of activation and clinical implications." Nature Reviews Endocrinology 6.9 (2010): 515-525.
description	18.	Levine, A. "Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies." Blood 114.1 (2009): 144-147.
description	19.	Breton, Breton V. "Prenatal Tobacco Smoke Exposure Affects Global and Gene-specific DNA Methylation." American Journal of Respiratory and Critical Care Medicine 180.5 (2009): 462-467.
description	20.	Lavoie HA, King SR;, S. "Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B." Experimental biology and medicine 234.8 (2009): 880-907.